Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
| Report ID | 124615 |
| Drug Identification Number | 02250306 |
| Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
| Common or Proper name | Ceftriaxone Sodium for Injection, BP |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 x 2g vial |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-09-30 |
| Estimated end date | |
| Actual end date | 2021-04-05 |
| Shortage status | Resolved |
| Updated date | 2021-04-06 |
| Company comments | Item is discontinued. |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.